Proposed change of auditors
Filed with HKEX · Stock code 512 · · 5 pages · English
Summary by 6ix AI
This decision is part of the company's strategy to enhance audit efficiency and support its overseas expansion. The proposed change is subject to shareholder approval at a special general meeting, where resolutions regarding the auditor transition will be presented. The board believes that this change will be in the best interests of the company and its shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Grand Pharmaceutical Group Limited on 6ix
Earlier from Grand Pharmaceutical
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Interim report 2026
- Notification Letter and Reply Form to Non-registered Shareholders - Notice of publication of Interim Report
- Notification Letter and Reply Form to Registered Shareholders - Notice of publication of Interim Report
- The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
Later from Grand Pharmaceutical
- Supplemental announcement in relation to proposed change of auditors
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
Follow Grand Pharmaceutical into a list and get an email when it puts out news.
Follow Grand Pharmaceutical